MONTANO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.755
EU - Europa 390
AS - Asia 233
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.385
Nazione #
US - Stati Uniti d'America 4.755
SG - Singapore 109
DE - Germania 74
UA - Ucraina 71
CN - Cina 68
SE - Svezia 64
IE - Irlanda 36
IT - Italia 33
GB - Regno Unito 28
HK - Hong Kong 26
RU - Federazione Russa 25
FR - Francia 18
FI - Finlandia 16
KR - Corea 14
BE - Belgio 10
KG - Kirghizistan 8
PL - Polonia 8
VN - Vietnam 5
AU - Australia 2
CL - Cile 2
ID - Indonesia 2
RO - Romania 2
AL - Albania 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
MA - Marocco 1
MD - Moldavia 1
NL - Olanda 1
PH - Filippine 1
SC - Seychelles 1
Totale 5.385
Città #
Woodbridge 1.529
Wilmington 1.282
Houston 962
Fairfield 151
Ann Arbor 146
Chandler 103
Ashburn 95
Singapore 85
Jacksonville 69
Cambridge 62
Seattle 62
Dearborn 40
Dublin 36
Medford 31
Hong Kong 26
Beijing 21
Zhengzhou 17
Lawrence 14
Brussels 10
Rome 10
Santa Clara 10
Mülheim 9
Shanghai 9
Los Angeles 8
San Mateo 8
Kraków 7
Boardman 6
Hefei 5
Menlo Park 5
Milan 5
Moscow 5
San Diego 5
University Park 5
Dong Ket 4
New York 4
Auburn Hills 3
Falls Church 3
Guangzhou 3
London 3
Phoenix 3
Verona 3
Hebei 2
Helsinki 2
Jakarta 2
Kilburn 2
Mountain View 2
Nanjing 2
Norwalk 2
Palo Alto 2
Washington 2
Baotou 1
Bologna 1
Cave 1
Chengdu 1
Chisinau 1
Crown City 1
Englewood 1
Fuzhou 1
Hanoi 1
Indiana 1
Kunming 1
Kunshan 1
Laurel 1
Manila 1
Melbourne 1
Nanning 1
Newark 1
Nuremberg 1
Pitesti 1
Redmond 1
Redwood City 1
Saint Paul 1
Saint Petersburg 1
San Francisco 1
Southwark 1
Stockholm 1
Tappahannock 1
Tirana 1
Warsaw 1
Yuncheng 1
Yunfu 1
Totale 4.913
Nome #
Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC) 465
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 459
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 438
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 425
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 399
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 386
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group 377
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 375
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 370
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 356
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 355
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children 346
Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. 324
Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy 321
Totale 5.396
Categoria #
all - tutte 10.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.251


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 0 0 138 110 97 107 69 84
2020/2021695 88 81 76 100 53 66 82 62 19 16 30 22
2021/2022191 7 19 20 12 12 19 10 4 15 19 8 46
2022/2023237 21 15 11 44 15 56 18 18 20 0 12 7
2023/202459 12 2 6 1 5 10 2 2 0 6 0 13
2024/2025198 14 75 39 15 19 36 0 0 0 0 0 0
Totale 5.396